USPTO serial 88234933
NEUROCURE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BELENKER, ESTHER
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with NEUROCURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
London WCIN 3AX, GB
London WCIN 3AX, GB
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Non-antibiotic Pharmaceutical preparation for skin care; Non-antibiotic Pharmaceutical preparation for the treatment of gout; Non-antibiotic pharmaceutical preparations acting on the central nervous system; Non-antibiotic Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Non-antibiotic pharmaceutical preparations for the treatment of itch, pain, neuropathy and inflammation in humans or animals by cooling the skin; Non-antibiotic Pharmaceutical preparations for treating allergies; Non-antibiotic Pharmaceutical preparations for treating hypertension; Non-antibiotic Pharmaceutical preparations for treating skin disorders; Non-antibiotic Pharmaceutical preparations for treating sunburn; Non-antibiotic Pharmaceutical preparations for use in chemotherapy; Non-antibiotic Pharmaceutical preparations for use in dermatology; Non-antibiotic Pharmaceutical products and preparations against dry skin and blemishes caused by pregnancy; Non-antibiotic pharmaceutical preparations for the treatment of itch, pain, neuropathy and inflammation related to diabetes, chemotherapy, radiotherapy, neuro-dermatitis, chickenpox, shingles, atopic dermatitis, eczema, psoriasis, urticaria (hives), multiple scelerosis, sciatica, migraine, sunburn, scars, varicose veins and skin rashes in humans or animals, all by cooling the skin; all the above-mentioned supplied in aerosol form | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 6, 2019 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Dec 6, 2019 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Dec 6, 2019 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Dec 6, 2019 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Aug 28, 2019 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| May 30, 2019 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Apr 30, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 30, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 15, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 19, 2019 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Feb 19, 2019 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jan 10, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 22, 2018 | NWAP | NEW APPLICATION ENTERED | — |